Department of Radiology

Publications

2020

Zein SA, Karakatsanis NA, Issa M, Haj-Ali AA, Nehmeh SA. Physical performance of a long axial field-of-view PET scanner prototype with sparse rings configuration: A Monte Carlo simulation study. Med Phys. 2020;47(4):1949-1957.

Kelly JM, Ponnala S, Amor-Coarasa A, Zia NA, Nikolopoulou A, Williams C, et al. Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for Cu/Cu-Based Theranostics in Prostate Cancer. Mol Pharm. 2020;17(6):1954-1962.

Yassin MA, Nehmeh SA, Nashwan AJ, Kohla SA, Mohamed SF, Ismail OM, et al. A study of 18F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia. Medicine (Baltimore). 2020;99(45):e23088.

Kamer AR, Craig RG, Niederman R, Fortea J, de Leon MJ. Periodontal disease as a possible cause for Alzheimer's disease. Periodontol 2000. 2020;83(1):242-271.

Zhang J, Winters K, Kiser K, Baboli M, Kim SG. Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: Comparison with conventional DCE-MRI. PLoS One. 2020;15(6):e0234520.

Habeck C, Gazes Y, Razlighi Q, Stern Y. Cortical thickness and its associations with age, total cognition and education across the adult lifespan. PLoS One. 2020;15(3):e0230298.

Gabr MT, Haywood T, Gowrishankar G, Srinivasan A, Gambhir SS. New synthesis of 6″-[ F]fluoromaltotriose for positron emission tomography imaging of bacterial infection. J Labelled Comp Radiopharm. 2020;63(11):466-475.

Gabr M, Rehman AU, Chen H-. Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling. ACS Med Chem Lett. 2020;11(9):1759-1765.

Al-Qatatsheh A, Morsi Y, Zavabeti A, Zolfagharian A, Salim N, Kouzani AZ, et al. Blood Pressure Sensors: Materials, Fabrication Methods, Performance Evaluations and Future Perspectives. Sensors (Basel). 2020;20(16).

Heacock L, Lewin A, Ayoola A, Moccaldi M, Babb JS, Kim SG, et al. Dynamic Contrast-Enhanced MRI Evaluation of Pathologic Complete Response in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer After HER2-Targeted Therapy. Acad Radiol. 2020;27(5):e87-e93.